← Back to Search

Behavioural Intervention

Oasis™ device for Tinnitus

N/A
Waitlist Available
Led By William A Ahroon, Ph.D.
Research Sponsored by United States Army Aeromedical Research Laboratory
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and two, four, and six months after enrollment

Summary

This trial tests a special sound therapy device designed to help soldiers and veterans with severe tinnitus. The device plays customized sounds, including music, to retrain the brain and reduce the perception of ringing in the ears. The goal is to improve their quality of life and ability to return to duty.

Eligible Conditions
  • Tinnitus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and six months after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and six months after enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Tinnitus Reaction Questionnaire (TRQ)
Secondary study objectives
Hospital Anxiety and Depression Scale (HADS)
Loudness Discomfort Levels (LDL) (an audiometric test)
Minimum Masking Level (MML) (an audiometric test)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Oasis™ deviceExperimental Treatment1 Intervention
Treatment using the Neuromonics Tinnitus Treatment Program and the Neuromonics Oasis™ treatment device.
Group II: Placebo devicePlacebo Group1 Intervention
Treatment using the Neuromonics Tinnitus Treatment Program and an identical-appearing placebo device.

Find a Location

Who is running the clinical trial?

United States Army Aeromedical Research LaboratoryLead Sponsor
4 Previous Clinical Trials
146 Total Patients Enrolled
Congressionally Directed Medical Research ProgramsFED
54 Previous Clinical Trials
9,501 Total Patients Enrolled
William A Ahroon, Ph.D.Principal InvestigatorU.S. Army Aeromedical Research Laboratory
~13 spots leftby Nov 2025